Myriad Genetics Inc
SWB:MYD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Myriad Genetics Inc
SWB:MYD
|
US |
|
Omnia Holdings Ltd
F:OHZ
|
ZA |
|
E
|
Elica SpA
F:7L4
|
IT |
|
MS&AD Insurance Group Holdings Inc
OTC:MSADY
|
JP |
|
Orient Overseas (International) Ltd
HKEX:316
|
HK |
|
Skeena Resources Ltd
TSX:SKE
|
CA |
|
Dream Impact Trust
F:6470
|
CA |
|
A
|
AMETEK Inc
XBER:AK1
|
US |
|
M
|
Medifast Inc
XMUN:MDF
|
US |
|
Housing Development Finance Corporation Ltd
NSE:HDFC
|
IN |
|
L
|
L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes Georges Claude SA
LSE:0NWF
|
FR |
|
Banca Popolare Di Sondrio SpA
MIL:BPSO
|
IT |
|
F
|
First Watch Restaurant Group Inc
NASDAQ:FWRG
|
US |
Wall St Price Targets
MYD Price Targets Summary
Myriad Genetics Inc
According to Wall Street analysts, the average 1-year price target for MYD is 5.667 EUR with a low forecast of 3.453 EUR and a high forecast of 8.974 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MYD's stock price target?
Price Target
5.667
EUR
According to Wall Street analysts, the average 1-year price target for MYD is 5.667 EUR with a low forecast of 3.453 EUR and a high forecast of 8.974 EUR.
What is the Revenue forecast for Myriad Genetics Inc?
Projected CAGR
6%
Over the last 4 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 5 years is 6%.
What is the Gross Profit forecast for Myriad Genetics Inc?
Projected CAGR
8%
Over the last 4 years, the compound annual growth rate for Gross Profit has been 4%. The projected CAGR for the next 4 years is 8%.
